Eguia-del Valle A, Martinez-Conde-Llamosas R, López-Vicente J, Uribarri-Etxebarria
A, Aguirre-Urizar JM. Salivary levels of Tumour Necrosis Factor-alpha in patients with recurrent aphthous stomatitis. Med Oral
Patol Oral Cir Bucal. 2011 Jan
1;16 (1):e33-6.
doi:10.4317/medoral.16.e33
http://dx.doi.org/doi:10.4317/medoral.16.e33
1. Ship JA. Recurrent aphthous stomatitis.
An update. Oral Surg
Oral Med Oral Pathol Oral Radiol
Endod. 1996;81:141-7.
doi:10.1016/S1079-2104(96)80403-3
2. Porter SR, Scully C, Pedersen A. Recurrent aphthous stomatitis. Crit Rev Oral Biol Med. 1998;9:306-21.
doi:10.1177/10454411980090030401
3. Rioboo-Crespo Mdel R, Planells-del Pozo P, Rioboo-García R. Epidemiology of the most common oral
mucosal diseases in children. Med Oral Patol
Oral Cir Bucal. 2005;10:376-87.
PMid:16264385
4. Pedersen A, Hougen HP, Kenrad B. T-lymphocyte subsets in oral mucosa of patients
with recurrent aphthous ulceration. J Oral Pathol Med. 1992;21:176-80.
doi:10.1111/j.1600-0714.1992.tb00097.x
PMid:1602409
5. Ship JA, Chavez EM, Doerr PA,
Henson BS, Sarmadi M. Recurrent aphthous
stomatitis. Quintessence Int. 2000;31:95-112.
PMid:11203919
6. Scully C, Gorsky M, Lozada-Nur F. The diagnosis and management of
recurrent aphthous stomatitis:
a consensus approach. J Am Dent Assoc. 2003;134:200-7.
PMid:12636124
7. Boras VV, Lukac J, Brailo
V, Picek P, Kordić D, Zilić IA. Salivary interleukin-6 and
tumor necrosis factor-alpha in patients with recurrent aphthous
ulceration. J Oral Pathol Med. 2006;35:241-3.
doi:10.1111/j.1600-0714.2006.00404.x
PMid:16519772
8. Natah
SS, Häyrinen-Immonen R, Hietanen
J, Malmström M, Konttinen
YT. Immunolocalization of tumor necrosis
factor-alpha expressing cells in recurrent aphthous
ulcer lesions (RAU). J Oral Pathol Med. 2000;29:19-25.
doi:10.1034/j.1600-0714.2000.290104.x
PMid:10678712
9. Tirelli AS, Colombo C, Torresani
E, Cariani L, Arnaboldi E, Conese M. Validation of an automated sensitive immunoassay
for quantitation of cytokines in the sputum of cystic
fibrosis patients. Clin Chem
Lab Med. 2007;45:108-11.
doi:10.1515/CCLM.2007.019
PMid:17243926
10. Berthier F, Lambert C, Genin
C, Bienvenu J. Evaluation of an automated immunoassay
method for cytokine measurement using the Immulite
Immunoassay system. Clin Chem
Lab Med. 1999;37:593-9.
doi:10.1515/CCLM.1999.092
PMid:10418750
11. Evereklioglu C, Er H, Türköz Y, Cekmen M. Serum levels
of TNF-alpha, sIL-2R, IL-6, and IL-8 are increased and associated with elevated
lipid peroxidation in patients with Behçet’s disease. Mediators Inflamm. 2002;11:87-93.
doi:10.1080/09629350220131935
PMid:12061429 PMCid:1781647
12. Saini A, Al-Shanti N,
Stewart CE. Waste management - cytokines, growth factors and cachexia. Cytokine Growth Factor Rev. 2006;17:475-86.
doi:10.1016/j.cytogfr.2006.09.006
13. Brabers NA, Nottet HS. Role of the
pro-inflammatory cytokines TNF-alpha and IL-1beta in HIV-associated dementia.
Eur J Clin Invest. 2006;36:447-58.
doi:10.1111/j.1365-2362.2006.01657.x
PMid:16796601
14. Sun A, Wang JT, Chia JS,
Chiang CP. Levamisole can modulate the serum tumor
necrosis factor-alpha level in patients with recurrent aphthous
ulcerations. J Oral Pathol Med. 2006;35:111-6.
doi:10.1111/j.1600-0714.2006.00383.x
PMid:16430742
15. Eguia A, Villarroel M, Martínez-Conde R, Echebarría MA, Aguirre JM. Adamantiades-Behçet disease: an enigmatic process with oral
manifestations. Med Oral Patol Oral
Cir Bucal. 2006;11:E6-11.
16. García Callejo FJ, Orts
Alborch MH, Morant Ventura
A, Segarra Cortés P, Marco Algarra
J. [Recurrent aphthous stomatitis
and clinical response to pentoxifylline]. Acta Otorrinolaringol Esp. 1999;50:671-3.
17. Vujevich J, Zirwas M.
Treatment of severe, recalcitrant, major aphthous stomatitis with adalimumab. Cutis.
2005;76:129-32.
PMid:16209159
18. Guimarães AL, Correia-Silva Jde
F, Sá AR, Victória JM, Diniz MG, Costa Fde O, et al. Investigation
of functional gene polymorphisms IL-1beta, IL-6, IL-10 and TNF-alpha in
individuals with recurrent aphthous stomatitis. Arch Oral Biol. 2007;52:268-72.
doi:10.1016/j.archoralbio.2006.08.008
PMid:17052682
19. Okada AA. Behçet’s disease: general concepts and
recent advances. Curr Opin Ophthalmol.
2006;17:551-6.
doi:10.1097/01.icu.0000247411.59213.bb
PMid:17065924
20. Hale S, Lightman S. Anti-TNF therapies in the
management of acute and chronic uveitis. Cytokine. 2006;33:231-7.
doi:10.1016/j.cyto.2005.12.012
PMid:16542849